國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
1.1.0 - Release1.1.0
國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
1.1.0 - Release1.1.0
This page is part of the 國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG) (v1.1.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: https://www.ghd.tw/cdm-fhir/ValueSet/CRLF-Chem-EH-vs | Version: 1.1.0 | |||
| Active as of 2024-09-01 | Computable Name: CRLFChemEHValueSet | |||
CRLF外院化學治療值集
References
Expansion performed internally based on codesystem 外院化學治療代碼系統 v1.1.0 (CodeSystem)
This value set contains 19 concepts
| System | Code | Display (zh) | JSON | XML |
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 00 | (1)未接受化學治療，化學治療非首次療程的一部份 (2)由屍體解剖時才診斷為癌症 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 01 | 接受全身性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 02 | 接受全身性化學治療，且只有一種化學藥物。(僅適用於 2017(含)診斷年之前的個案) | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 03 | 接受全身性化學治療，且超過一種以上的化學藥物。(僅適用於 2017(含)診斷年之前 的個案) | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 04 | 個案原發部位僅接受局部動脈栓塞化學治療(TACE) | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 05 | 個案原發部位接受局部動脈栓塞化學 (TACE)及全身性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 06 | 個案原發部位接受局部動脈栓塞化學 (TACE)及其他局部性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 07 | 個案原發部位接受局部動脈栓塞化學 (TACE)、其他局部性及全身性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 08 | 個案僅接受局部性化學治療(不包含TACE) (1)肋膜腔注射 (2)心包膜腔注射 (3)腹腔內注射 (4)膀胱灌注 (5)脊髓腔內注射(intrathecal) (6)其他局部化學治療(例如：BCNU wafer implantation) | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 09 | 個案同時接受全身性及局部性化學治療(不包含TACE) | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 10 | 肝轉移個案接受局部動脈栓塞化學治療(TACE) | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 11 | 肝轉移個案接受局部動脈栓塞化學(TACE)及全身性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 12 | 肝轉移個案接受局部動脈栓塞化學治療(TACE)及其他局部性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 13 | 肝轉移個案接受局部動脈栓塞化學治療(TACE)、其他局部性及全身性化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 20 | 僅接受臨床試驗化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 21 | 同時接受化學治療(全身性或/與局部性)及臨床試驗化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 30 | 僅接受雙盲試驗化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 31 | 同時接受化學治療(全身性或/與局部性)及雙盲試驗化學治療 | ||
https://www.ghd.tw/cdm-fhir/CodeSystem/CRLF-Chem-EH-cs | 99 | (1)由於病歷未記載，所以不知道化學治療是否有被建議或是已經執行 (2)僅由死亡證明書得知個案有癌症 |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |